Skip to main content
. 2021 Apr 1;9(4):738. doi: 10.3390/microorganisms9040738

Table A1.

PSERENADE team.

Name Affiliation
Zahin Amin-Chowdhury Immunisation and Countermeasures Division, Public Health England, London NW9 5EQ, UK
Rita Born Federal Office of Public Health, 3097 Liebefeld, Switzerland
Maria-Cristina C. Brandileone National Laboratory for Meningitis and Pneumococcal Infections, Center of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo 01246-902, Brazil
Dana Bruden Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA
Carrie L. Byington University of Utah Department of Pediatrics (emeritus), Salt Lake City, UT 84108, United States; University of California Health System, Oakland, CA 94607, USA
Claire Cameron Public Health Scotland, Glasgow G2 6QE, UK
Jesús Castilla Instituto de Salud Pública de Navarra—IdiSNA, 31003 Pamplona, Navarra, Spain; CIBER Epidemiología y Salud Pública, (CIBERESP), 28029 Madrid, Spain
Guanhao Chan Singapore Ministry of Health, Communicable Diseases Division, Singapore 308442, Singapore
Kin-Hung Chow Department of Microbiology and Carol Yu Centre for Infection, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
Tine Dalby Bacteria, Parasites and Fungi, Statens Serum Institut, DK-2300 Copenhagen S, Denmark
Kostas Danis Santé Publique France, the French National Public Health Agency, Saint Maurice CEDEX, 94415 Paris, France
Linda de Gouveia Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Sandringham, 2192 Johannesburg, South Africa
Sara de Miguel Epidemiology Department, Dirección General de Salud Pública, 28009 Madrid, Spain
Geneviève Deceuninck Quebec University Hospital Research Centre, Québec, QC G1V 4G2, Canada
Martina Del Manso Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), 00161 Rome, Italy
Janepsy Díaz Instituto de Salud Pública de Chile, 7780050 Santiago, Santiago Metropolitan, Chile
Elina Dimina Centre for disease prevention and control of Latvia, 1005 Riga, Latvia
Helga Erlendsdottir Department of Clinical Microbiology, Landspitali—The National University Hospital, Hringbraut, 101 Reykjavik, Iceland
Noga Givon-Lavi Pediatric Infectious Disease Unit and Clinical Microbiology Laboratory, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel
James D. Kellner Department of Pediatrics, University of Calgary, and Alberta Health Services, Calgary, AB T3B 6A8, Canada
Mirjam J. Knol National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands
Brigitte Lefebvre Laboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Quebec City, QC H9X 3R5, Canada
Jolita Mereckiene HSE Health Protection Surveillance Centre, Mountjoy, D01 A4A3 Dublin, Ireland
Carmen Muñoz-Almagro Molecular Microbiology Department, Hospital Sant Joan de Déu Research Institute, 08950 Esplugues de Llobregat, Barcelona, Spain; Medicine Department, Universitat Internacional de Catalunya, 08017 Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
Daniela Napoli Servicio de Bacteriología Clínica, Departamento de Bacteriología, INEI—ANLIS “Dr. Carlos G. Malbrán”, C1282 AFF Buenos Aires, Argentina
Néhémie Nzoyikorera Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca 20000, Morocco; Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca 20250, Morocco
Stephen I. Pelton Boston University Schools of Medicine and Public Health, Boston, MA 02118, USA
Kate Pennington Communicable Disease Epidemiology and Surveillance Section, Office of Health Protection, Australian Government Department of Health, Canberra, ACT 2606, Australia
Tamara Pilishvili National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Marie-Cecile Ploy University Hospital Centre Limoges, Regional Observatories for Pneumococci, 87000 Limoges, France
Rodrigo Puentes Instituto de Salud Pública de Chile, 7780050 Santiago, Santiago Metropolitan, Chile
Shigeru Suga Infectious Disease Center and Department of Clinical Research, National Hospital Organization Mie Hospital, Tsu, Mie 514-0125, Japan
Catherine G. Sutcliffe Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
Todd D. Swarthout NIHR Global Health Research Unit on Mucosal Pathogens, Division of Infection and Immunity, UCL, Bloomsbury, London WC1E 6BT, UK; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, P.O. Box 30096, Chichiri, Blantyre 3, Malawi
Koh Cheng Thoon KK Women’s and Children’s Hospital, Singapore 229899, Singapore
Maija Toropainen Department of Health Security, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland
Didrik F. Vestrheim Department of Infection Control and Vaccine, Norwegian Institute of Public Health, 0456 Oslo, Norway
Anne von Gottberg Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Sandringham, 2192 Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein 2000, Johannesburg, South Africa
Toronto Invasive Bacterial Diseases Network
WHO Invasive Bacterial Vaccine-Preventable Diseases (IB-VPD) Network